Resilient Together for Dementia
RT-D ADRD
2 other identifiers
interventional
12
1 country
1
Brief Summary
The proposed study will establish the feasibility, acceptability and credibility of a novel live video dyadic resiliency intervention, Resilient Together for Dementia (RT-D), aimed at preventing chronic emotional distress and preserving quality of life among dyads at risk for chronic emotional distress early after a diagnosis of Alzheimer's disease or a related dementia (ADRD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 19, 2024
CompletedFirst Submitted
Initial submission to the registry
April 30, 2024
CompletedFirst Posted
Study publicly available on registry
May 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 6, 2025
CompletedMarch 30, 2025
March 1, 2025
11 months
April 30, 2024
March 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of potential eligible participants
Feasibility of recruitment - Recruitment will be monitored by screening clinic visits for potentially eligible individuals and review recruitment progress in weekly meetings to promote completion within the study time frame. Recruitment will be monitored but will not set official benchmarks and modify procedures after each dyad.
After each dyad completion, throughout study of 1.5-2 months
Secondary Outcomes (4)
Proportion of participants screened
After each dyad completion, throughout study of 1.5-2 months
Proportion of participants who consent or not consent to participate
After each dyad completion, throughout study of 1.5-2 months
Proportion of sessions participants attend
After each dyad completion, throughout study of 1.5-2 months
Change in Hospital Anxiety and Depression Scale (HADS)
Baseline and 6 weeks (post-intervention)
Study Arms (1)
Open Pilot RT-D Dyads
EXPERIMENTALPersons living with dementia (PWDs) and their spousal care-partners
Interventions
A novel live video dyadic resiliency intervention
Eligibility Criteria
You may qualify if:
- Recent (\~1 month) chart documented ADRD diagnosis,
- ADRD symptom onset after age 65 ,
- cognitive assessment scores and symptoms consistent with early stage dementia, as determined by the Clinical Dementia Rating Scale scores of .5 or 1.0
- cognitive awareness of his/her problems (as determined by the treating neurologist), and
- ability to understand study and research protocol, as determined by a standardized teach-back method assessment84.
- English speaking adults (18 years or older),
- dyad lives together,
- at least one partner endorses clinically significant emotional distress during screening (\>7 on Hospital Anxiety and Depression scale subscales)
You may not qualify if:
- patient is deemed inappropriate by the neurology team,
- either partner has a co-occurring terminal illness,
- patient was diagnosed with forms of dementia with clinical profiles that would preclude participation (e.g., Frontotemporal Dementia- behavioral variant), as determined by treatment team.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brain Injury Research Center at Mount Sinai
New York, New York, 10029, United States
Related Publications (1)
McCage S, Walker K, Cornelius T, Parker RA, Dams-O'Connor K, Dickerson B, Ritchie C, Vranceanu AM, Bannon S. A Live Video Resiliency Dyadic Intervention for Persons With Dementia and Their Care-Partners Early After Diagnosis: Protocol for Open Pilot of Resilient Together for Dementia. JMIR Res Protoc. 2025 Jan 15;14:e60382. doi: 10.2196/60382.
PMID: 39814366DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Bannon
Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 30, 2024
First Posted
May 20, 2024
Study Start
April 19, 2024
Primary Completion
March 6, 2025
Study Completion
March 6, 2025
Last Updated
March 30, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Immediately following publication. No end date.
- Access Criteria
- Anyone who wishes to access the data. Any purpose. Data are available indefinitely at (Link tbd).
All of the individual participant data collected during the trial, after deidentification.